All articles by Staff Writer
Staff Writer
Co-Dx and CoSara inaugurate oligo synthesis facility in Ranoli, India
Co-Dx and our Indian joint venture, CoSara Diagnostics Pvt. Ltd, inaugurated the oligonucleotide synthesis facility in Ranoli, India on December 11, 2024. The new facility is designed to support the “Make in India” initiative by manufacturing our patented Co-Primers® chemistry, which has been used in the Co-Dx and CoSara lab-based PCR tests for years, and will also power the test cups for the upcoming Co-Dx PCR at-home and POC testing platform.*
Cormica expands European operations with acquisition of Zwisler Laboratorium GmbH
Cormica, a global leader in life sciences testing and consulting, has completed the acquisition of Zwisler Laboratorium, a premier provider of laboratory services headquartered in Reichenau, Germany.
QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory clearance of the first in a series of QIAstat-Dx Gastrointestinal Panel tests for clinical use.
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analyzed from a single biological sample.
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial, fungal and viral targets.
BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts
Company continues to advance its placental-derived product portfolio with the first patent granted in the fenestrated wound care market
Is Technology the Key to Future Proofing Our Healthcare System?
If we want to reduce the shocks and stress felt when the world around us seems to shatter – or just simply grows bigger – we can’t wait ‘for the money to come in’ or a policy push to make things easier for healthcare providers or patients. We must make one simple change – then repeat.
Arab Health to celebrate 50th edition in 2025
Arab Health, the Middle East’s largest and most important healthcare event and congress, will celebrate its 50th edition when it returns to the Dubai World Trade Centre (DWTC) from 27 – 30 January 2025. The show will attract an international audience under the theme of ‘Where the world of healthcare meets’.
Rapid tests for a rapid response to AMR
With antimicrobial resistance (AMR) reaching a crisis point in modern healthcare systems, Certest offers a way to help detect infections before they could possibly wreak havoc in a healthcare environment.
Minimum input, maximum output
Minimally invasive surgery has revolutionised the surgical fi eld over the past 40 years, especially given the rise of robotic-assisted systems. However, there are still many challenges remaining for medical researchers to address. Abi Millar speaks to Kaspar Althoefer of Queen Mary University of London, and Maria Leiloglou, CEO of EnAcuity, about the most exciting new technologies that are making inroads in this space.